Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)
CompletedOBSERVATIONAL
Enrollment
68
Participants
Timeline
Start Date
November 2, 2022
Primary Completion Date
December 2, 2022
Study Completion Date
December 2, 2022
Conditions
Type 2 Diabetes Mellitus
Trial Locations (1)
91106
Centre Hospitalier Sud Francilien, Corbeil-Essonnes
All Listed Sponsors
lead
Centre Hospitalier Sud Francilien
OTHER
NCT05331339 - Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES) | Biotech Hunter | Biotech Hunter